Skip to content

Study · Animal study (in vivo) · goldfish · 2021

1 result

Intracerebroventricular administration of α-melanocyte-stimulating hormone (α-MSH) enhances thigmotaxis and induces anxiety-like behavior in the goldfish Carassius auratus.

Watanabe K, Konno N, Nakamachi T, Matsuda K

Peptides8 Aug 2021Cited by 9 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In goldfish, intracerebroventricular melanotan II at 50 pmol/g body weight mimicked the action of alpha-MSH, which prolonged the time spent in the edge area of the tank.

    In plain wordsIn goldfish, melanotan II injected into the brain had a similar effect to alpha-MSH, which made fish stay longer at the tank edge.

    Outcome
    IncreaseTime spent in the edge area of the tank (thigmotaxis)
    Study

    goldfishn: not reported in source

    Carassius auratus, edge-preference test
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    50 pmol/g body weight · intracerebroventricularAs given in this study (goldfish).

    Source sentences

    Summary
    The action of α-MSH mimicked those of FG-7142 (a central-type benzodiazepine receptor (CBR) inverse agonist with an anxiogenic effect) at 10 pmol g-1 BW and melanotan II (a melanocortin 4 receptor (MC4R) agonist) at 50 pmol g-1 BW
    1 context sentence
    Summary · context
    When α-MSH was administered ICV at 1 and 10 pmol g-1 body weight (BW), the time spent in the edge area of a tank was prolonged at 10 pmol g-1 BW.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.